HUP0200993A2 - Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them - Google Patents

Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them

Info

Publication number
HUP0200993A2
HUP0200993A2 HU0200993A HUP0200993A HUP0200993A2 HU P0200993 A2 HUP0200993 A2 HU P0200993A2 HU 0200993 A HU0200993 A HU 0200993A HU P0200993 A HUP0200993 A HU P0200993A HU P0200993 A2 HUP0200993 A2 HU P0200993A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
thio
oxindole derivatives
producing
compositions containing
Prior art date
Application number
HU0200993A
Other languages
Hungarian (hu)
Inventor
Andrew Fensome
Todd K. Jones
Marci C. Koko
Keith B. Marschke
Christopher M. Tegley
Puwen Zhang
Lin Zhi
Original Assignee
Ligand Pharmaceuticals, Inc.
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,033 external-priority patent/US6355648B1/en
Application filed by Ligand Pharmaceuticals, Inc., Wyeth filed Critical Ligand Pharmaceuticals, Inc.
Publication of HUP0200993A2 publication Critical patent/HUP0200993A2/en
Publication of HUP0200993A3 publication Critical patent/HUP0200993A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HU0200993A 1999-05-04 2000-05-01 Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them HUP0200993A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17225999P 1999-05-04 1999-05-04
US09/552,033 US6355648B1 (en) 1999-05-04 2000-04-19 Thio-oxindole derivatives

Publications (2)

Publication Number Publication Date
HUP0200993A2 true HUP0200993A2 (en) 2002-07-29
HUP0200993A3 HUP0200993A3 (en) 2003-05-28

Family

ID=26867898

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200993A HUP0200993A3 (en) 1999-05-04 2000-05-01 Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them

Country Status (18)

Country Link
EP (1) EP1181275A1 (en)
JP (1) JP2002543182A (en)
KR (1) KR20020000636A (en)
CN (1) CN1143847C (en)
AU (1) AU767762B2 (en)
BG (1) BG106078A (en)
BR (1) BR0010216A (en)
CA (1) CA2371633A1 (en)
CZ (1) CZ20013950A3 (en)
EA (1) EA005034B1 (en)
GE (1) GEP20043266B (en)
HU (1) HUP0200993A3 (en)
MX (1) MXPA01011285A (en)
NO (1) NO320912B1 (en)
NZ (1) NZ515351A (en)
PL (1) PL351407A1 (en)
SK (1) SK15902001A3 (en)
TR (1) TR200103288T2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005010065D1 (en) * 2004-04-08 2008-11-13 Wyeth Corp METHOD FOR MINIMIZING THIOAMID POLLUTION
CN100522960C (en) * 2004-04-08 2009-08-05 惠氏公司 Thioamide derivatives as progesterone receptor modulators
GB201113538D0 (en) * 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN104995194B (en) * 2012-10-12 2017-08-29 学校法人冲绳科学技术大学院大学学园 Spiro indole derivative and preparation method thereof
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
EP3519393B1 (en) * 2016-09-30 2022-05-18 Epizyme Inc Substituted fused bi- or tri- heterocyclic compounds as ehmt2 inhibitors

Also Published As

Publication number Publication date
NO20015380D0 (en) 2001-11-02
BG106078A (en) 2002-05-31
NO320912B1 (en) 2006-02-13
JP2002543182A (en) 2002-12-17
KR20020000636A (en) 2002-01-05
NZ515351A (en) 2004-01-30
EA200101180A1 (en) 2002-04-25
MXPA01011285A (en) 2003-09-04
CN1349499A (en) 2002-05-15
PL351407A1 (en) 2003-04-22
EA005034B1 (en) 2004-10-28
CA2371633A1 (en) 2000-11-09
CN1143847C (en) 2004-03-31
AU767762B2 (en) 2003-11-20
EP1181275A1 (en) 2002-02-27
GEP20043266B (en) 2004-06-25
SK15902001A3 (en) 2002-11-06
CZ20013950A3 (en) 2002-06-12
AU4681400A (en) 2000-11-17
TR200103288T2 (en) 2002-04-22
NO20015380L (en) 2002-01-03
HUP0200993A3 (en) 2003-05-28
BR0010216A (en) 2002-03-19

Similar Documents

Publication Publication Date Title
HUP0203548A3 (en) New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0300618A3 (en) Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0204245A3 (en) Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0000748A3 (en) 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0203316A3 (en) Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0105114A3 (en) Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0203294A3 (en) Benzodiazepine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0204226A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP0203052A3 (en) Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201516A3 (en) 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201753A3 (en) Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203184A3 (en) Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203385A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
PL352293A1 (en) Derivatives of purine, method of making same and pharmaceutical compositions containing these derivatives
HUP0202731A3 (en) O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
HUP0201315A3 (en) 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0105479A3 (en) Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0101482A3 (en) Piperidinyl and n-amidinopiperidinyl derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
HUP0102895A3 (en) Cyclopentanone dihydropyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
PL352280A1 (en) Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives
HUP0201797A3 (en) 3-amino-2-benzyl-1-phenyl-propane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0202371A3 (en) Diacylhydrazine derivatives, process for producing them, use of these derivatives for producing of pharmaceutical compositions and pharmaceutical compositions

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: WYETH, US

Free format text: FORMER OWNER(S): AMERICAN HOME PRODUCTS CORPORATION, US; LIGAND PHARMACEUTICALS, INC., US; WYETH, US

FD9A Lapse of provisional protection due to non-payment of fees